Google Changes EU Spam Policy Amid Antitrust Scrutiny 
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns 
Trump Secures Drug Pricing Deals With Nine Pharma Companies 
GM Canada Workers Approve C$1.1 Billion Investment Deal 
CIA-Linked Investor Helped Quantum Systems Expand in US 
Trump Administration Plans New Drug Pricing Deals With Biotech Firms 
Mercer International Stock Surges 45% on C$20 Million Canada Funding 
Itochu Offers $1.56 Billion to Privatize Dentsu Soken 
Trump Says ExxonMobil Among Oil Majors Planning Venezuela Return 
Honda, Nissan Eye Shared Vehicle Software Platform by 2029 
PayPal Shares Sink as $50 Billion Takeover Bid Collapses 
Toyota Global Sales Fall as China Demand Slumps 
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition 
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14% 
Star Entertainment Shares Fall After A$307 Million FY2026 Loss 
Amazon Shares Fall as FTC Plans Ad Pricing Lawsuit 
Street Poller Media and The Boom of the Street Interview Ad Industry 
Add as a preferred source on Google
DAVIS, Calif., April 02, 2018 -- Marrone Bio Innovations, Inc. (the “Company” or “MBI”) (NASDAQ:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that management is scheduled to present at The MicroCap Conference in New York City. The conference is being held on April 9-10, 2018 at the JW Marriott Essex House.
Marrone Bio Innovations management will host one-on-one meetings throughout the day and is scheduled to present as follows:
The MicroCap Conference
Date: Monday, April 9, 2018
Presentation Time: 9:00 a.m. Eastern time
Location: Track 3, JW Marriott Essex House – 160 Central Park S, New York, NY
Webcast: http://www.investorcalendar.com/event/27275
Registration is mandatory for conference participation. For more information on the conference or to schedule a one-on-one meeting, please visit the conference website, http://microcapconf.com.
About Marrone Bio Innovations
BIO WITH BITE.
Marrone Bio Innovations, Inc. (NASDAQ:MBII) strives to lead the movement to a more sustainable world through the discovery, development and promotion of biological products for pest management and plant health. MBI’s effective and environmentally responsible pest management solutions help customers operate more sustainably while uniquely improving plant health and increasing crop yields. MBI’s currently available commercial products are Regalia®, Grandevo®, Venerate®, Majestene®, Haven® StargusTM, AmplitudeTM, ZeltoTM and Zequanox®. MBI also distributes Bio-tam 2.0® for Isagro USA and Jet-Ag® for Jet Harvest in most regions of the U.S.
Marrone Bio Innovations is dedicated to pioneering smart biopesticide solutions that support a better tomorrow for both farmers and consumers around the globe. For more information, please visit www.marronebio.com.
Marrone Bio Innovations Contacts:
Pam Marrone, CEO and Founder
Telephone: +1 (530) 750-2800
Email: [email protected]
Investor Relations:
Greg Falesnik
Managing Director
MZ Group – MZ North America
Main: 949-385-6449
[email protected]
www.mzgroup.us
